LakeShore Biopharma Co., Ltd: shares_wavg_diluted
| Value | {"unit": "shares", "value": 6178547, "concept": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"} |
|---|---|
| Period | 2022-04-01 – 2023-03-31 |
| Status | current |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/007c32de-6984-42f5-9bea-06adfbad0509
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-069880Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/shares-wavg-diluted/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/007c32de-6984-42f5-9bea-06adfbad0509
History
- supersedes {"unit": "shares", "value": 61785466, "concept": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"} (evidence 0001213900-24-069344)